News Articles http://www.drugdiscoveryonline.com/ 11/30/2008 2:50:00 AM ChemDiv, Inc. and Orion Pharma recently announced that Orion has chosen ChemDiv as a discovery partner in small molecule therapeutics for Orion's priority targets. http://www.drugdiscoveryonline.com/article.mvc/Orion-Pharma-Selects-Chemdiv-As-A-Partner-In-0002?atc~c=771+s=773+r=001+l=a 11/30/2008 2:50:00 AM The total drug discovery market in Western Europe was worth $17.40 billion in 2007, and Frost & Sullivan expects this to grow at a compound annual growth rate of 13.5% to reach $42.08 billion by 2014 http://www.drugdiscoveryonline.com/article.mvc/Drug-Discovery-Research-Turns-To-Biomarkers-0003?atc~c=771+s=773+r=001+l=a 10/1/2008 4:18:00 AM The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium http://www.drugdiscoveryonline.com/article.mvc/National-Cancer-Institute-Selects-CambridgeSo-0001?atc~c=771+s=773+r=001+l=a 10/1/2008 4:06:41 AM ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008, at 1:00 p.m http://www.drugdiscoveryonline.com/article.mvc/ACADIA-Pharmaceuticals-To-Present-At-The-JMP-0001?atc~c=771+s=773+r=001+l=a 10/1/2008 3:55:00 AM The strong emphasis that TEMIS, the leading provider of Text Analytics solutions, has put on the Life Science market since many years has led to another important licensing agreement http://www.drugdiscoveryonline.com/article.mvc/TEMIS-Text-Analytics-Solution-Luxid-For-0001?atc~c=771+s=773+r=001+l=a 9/29/2008 4:13:00 AM RainDance Technologies announced recently the launch of the dScreen Consortium, a research initiative conducted with sanofi-aventis, Paris , and Louis Pasteur University of Strasbourg, France, to develop the next generation of high-throughput screening (HTS) for drug discovery applications http://www.drugdiscoveryonline.com/article.mvc/RainDance-Technologies-Signs-A-Collaboration-0001?atc~c=771+s=773+r=001+l=a 9/29/2008 4:00:00 AM FEI Company , a leading provider of high-resolution imaging and analysis systems, announced recently the installation of a solution based upon FEI's Tecnai Spirit cryo-transmission electron microscope (TEM) and three-dimensional (3D) tomography software at Sun Pharmaceutical Industries, Ltd. http://www.drugdiscoveryonline.com/article.mvc/Sun-Pharma-Chooses-FEI-Solution-For-0001?atc~c=771+s=773+r=001+l=a 9/29/2008 2:17:00 AM Critical Outcome Technologies Inc. , announced recently that it has entered into an agreement with a major pharmaceutical company to advance up to six drug candidates from COTI's HIV-1 integrase inhibitor program, identified using its CHEMSAS drug discovery process http://www.drugdiscoveryonline.com/article.mvc/Critical-Outcome-Technologies-Inc-To-Advance-0001?atc~c=771+s=773+r=001+l=a 9/24/2008 4:37:00 AM Southern Research Institute recently announced the creation of BioSafety Solutions LLC (BSL), a consulting company that will provide services ranging from technical and operational support for existing biosafety and biosecurity programs, to the development and implementation of comprehensive programs for high containment laboratories and organizations involved in life science research and development http://www.drugdiscoveryonline.com/article.mvc/Southern-Research-Institute-Launches-0001?atc~c=771+s=773+r=001+l=a 9/22/2008 2:26:00 AM The National Foundation for Cancer Research (NFCR), a Bethesda-based leading cancer research charity in the US, and InhibOx, a computational drug discovery company located in Oxford, UK, announced recently that they have joined forces to launch a powerful new computational drug screening tool, DrugFinder http://www.drugdiscoveryonline.com/article.mvc/InhibOx-And-The-National-Foundation-For-0001?atc~c=771+s=773+r=001+l=a 9/19/2008 4:28:00 AM Systat Software, Inc., announced recently that it has signed an agreement with Genomatix Software, Inc., a wholly owned subsidiary of Genomatix Software, GmbH of Munich, Germany, making Systat Software, Inc., the exclusive distributor for Genomatix' on line software and data base products in the North American Academic and Government(non-NIH) market. http://www.drugdiscoveryonline.com/article.mvc/Systat-Distribute-Genomatix-Software-Products-0001?atc~c=771+s=773+r=001+l=a 9/16/2008 7:45:00 AM OriGene Technologies, Inc. announces it has launched a new product line for antibody validation - VERIFY™ Antigen Standard - a collection of tagged over-expression cell lysates to be used as Western blot standards. http://www.drugdiscoveryonline.com/article.mvc/Human-Antigen-Standards-Antibody-Validation-0001?atc~c=771+s=773+r=001+l=a 9/15/2008 4:22:00 PM Cellumen, Inc., a discovery toxicology company,announced an agreement with Mitsubishi Tanabe Pharma Corporation, one of the leading pharmaceutical companies in Japan, to develop panels of biomarkers that identify toxicity early in the drug development process http://www.drugdiscoveryonline.com/article.mvc/Cellumen-And-Mitsubishi-Tanabe-Pharma-0001?atc~c=771+s=773+r=001+l=a 9/4/2008 4:20:00 AM Covidien, a leading global provider of healthcare products, today announced that its Mallinckrodt Baker business has entered into a licensing and commercialization agreement with drug development research specialist Rubicon Research http://www.drugdiscoveryonline.com/article.mvc/Mallinckrodt-Baker-And-Rubicon-Research-Sign-0001?atc~c=771+s=773+r=001+l=a 9/4/2008 2:36:45 AM Curis, Inc.a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment today announced that the first patient has been treated in a Phase I clinical trial of CUDC-101, a first-in-class small molecule drug candidate that has been designed as an inhibitor of epidermal growth factor receptor http://www.drugdiscoveryonline.com/article.mvc/Curis-Announces-Dosing-Of-First-Patient-In-0001?atc~c=771+s=773+r=001+l=a 9/4/2008 2:26:49 AM Guava Technologies, Inc. announced the commencement of an agreement with Hudson Control Group to provide drug discovery researchers with an automated solution for cellular analyses http://www.drugdiscoveryonline.com/article.mvc/San-Francisco-Bay-Area-Cell-Analysis-Company-0002?atc~c=771+s=773+r=001+l=a 8/28/2008 1:33:00 AM Heptares Therapeutics Ltd, the drug discovery company focused on the design and development of novel drugs based on G-protein-coupled receptors notes that a new academic publication by the research group led by one of its scientific founders (Ref. 1) further validates the potential of its proprietary technology for creating purified, functional and stable G-protein receptors (GPCRs) for drug discovery and structural studies http://www.drugdiscoveryonline.com/article.mvc/Academic-Publication-Highlights-Method-For-0001?atc~c=771+s=773+r=001+l=a 8/28/2008 1:21:00 AM Particle Sciences Inc. recently announced the development of their "Microreservoir" technology enabling the manufacture of drug-eluting polymer medical devices that release drugs at constant rates over 30 days or more. This technology has already been used by Particles Sciences to develop drug eluting vaginal rings http://www.drugdiscoveryonline.com/article.mvc/Particle-Sciences-Develops-Zero-Order-Release-0001?atc~c=771+s=773+r=001+l=a 8/26/2008 11:40:00 PM Genevac has announced the introduction of the VirTis Ultra Series Freeze Dryer has been engineered to handle a wide range of applications from phase one research through to production clinical trial batches http://www.drugdiscoveryonline.com/article.mvc/Freeze-Dryer-Offers-Larger-Batch-Processing-0001?atc~c=771+s=773+r=001+l=a 8/26/2008 8:57:00 AM Baxter Healthcare Corporation recently announced a licensing agreement with Innocoll Pharmaceuticals Ltd, a division of Innocoll, Inc., granting Baxter exclusive rights to market and distribute the company's gentamicin surgical implant in the United States http://www.drugdiscoveryonline.com/article.mvc/Baxter-Announces-Licensing-Agreement-For-0001?atc~c=771+s=773+r=001+l=a 8/25/2008 2:17:00 AM